See more : Verisk Analytics, Inc. (0LP3.L) Income Statement Analysis – Financial Results
Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Advagene Biopharma Co., Ltd. (6709.TWO) Income Statement Analysis – Financial Results
- Indara Insurance Public Company Limited (INSURE.BK) Income Statement Analysis – Financial Results
- Longeveron Inc. (LGVN) Income Statement Analysis – Financial Results
- Strike Company,Limited (6196.T) Income Statement Analysis – Financial Results
- AbbVie Inc. (4AB.DE) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
| Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
| General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
| Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
| SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
| Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
| Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
| EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
| Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
| Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
| EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
| Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical Announces Departure of Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO),...
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants...
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the third quarter ended September...
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson...
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
Vicarious Surgical Announces Reverse Stock Split
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will effect a 1-for-30 reverse stock split of...
RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024
Vicarious Surgical (NYSE: RBOT ) just reported results for the first quarter of 2024. Vicarious Surgical reported earnings per share of -9 cents.
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - Head, Investor Relations Adam Sachs - Co-Founder and CEO Bill Kelly - Chief Financial Officer Randy Clark - President...
Vicarious Surgical Reports First Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced financial results for the quarter ended March 31, 2024....
Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter...
Source: https://incomestatements.info
Category: Stock Reports